🔎 Trials Near Me

Akèy › Amiloidoz › Pennsylvania › Philadelphia

Etid klinik pou Amiloidoz nan Philadelphia, PA

7 etid pou Amiloidoz ap chèche patisipan nan sit nan ak bò kote Philadelphia (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis

Ap rekriteFaz 1
  • University of Pennsylvania Division of Hematology Oncology Perelman Center for Advanced Medicine, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT05652335

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

Ap rekriteEtid obsèvasyon
  • Research Site, Philadelphia
  • Research Site, Philadelphia
Laj 18 a 130 · Tout sèks · Mizajou Sep 23, 2026 · NCT06465810

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

Ap rekriteFaz 3
  • Clinical Trial Site, Philadelphia
Laj 18 a 85 · Tout sèks · Mizajou Sep 16, 2026 · NCT07052903

DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting

Ap rekriteEtid obsèvasyon
  • Clinical Trial Site, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07358078

ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)

Ap rekriteEtid obsèvasyon
  • Clinical Trial Site, Philadelphia
Tout laj · Tout sèks · Mizajou Sep 8, 2026 · NCT04561518

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

Ap rekriteFaz 3
  • Penn Presbyterian Medical Center, Philadelphia
Laj 18 a 75 · Tout sèks · Mizajou Aug 4, 2026 · NCT06563895

MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

Ap rekriteFaz 3
  • Penn Presbyterian Medical Center, Philadelphia
Laj 18 a 90 · Tout sèks · Mizajou Mar 27, 2026 · NCT06128629

Etid Amiloidoz nan lòt vil

Lòt etid nan Philadelphia

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.